There are currently no licensed vaccines to treat norovirus, a highly contagious virus that causes sickness and diarrhoea.

We recently published a list of 10 Best Depressed Stocks To Buy Heading into 2025. In this article, we are going to take a ...

The first phase 3 randomised clinical trial of an investigational mRNA norovirus vaccine will open across the UK within the next two weeks. Sponsored by Moderna, the trial evaluates the efficacy and ...

The jab uses mRNA technology to tell the immune system to recognise a ‘foreign’ protein on viruses and mount an attack.

Dr Patrick Moore, the study's chief investigator and the National Institute for Health and Care Research (NIHR) director in ...

A first-of-its-kind study testing an mRNA vaccine for norovirus, the highly contagious winter vomiting bug, is launching in ...

(see more details here). Moderna, Inc. (NASDAQ:MRNA) is a biotechnology company that is best known for its coronavirus ...

The FDA approves Pfizer's RSV vaccine, Abrysvo, for adults aged 18-59 years with increased risk of the disease.

Experts hope the Moderna jab could stop people developing the vomiting and diarrhoea bug, which is linked to around 12,000 ...

A trial in the UK will see a norovirus given to patients with the Health Secretary hoping it will cut the “burden on the NHS”.

It is hoped the new norovirus jab could help lift the burden on the NHS over the busy winter months - here we explain who is ...

This isn’t just about patients getting ill. A vaccine could also help prevent healthcare staff absences, with current NHS ...